Highlights for November 2017

  1. Piramal acquires Digeplex from Shreya Lifesciences
  2. Morepen signs agreement with Vesale Pharma
  3. Eris Life to acquire Strides' India business for INR 500 crores
  4. Intas closing in on Mallinckrodt’s US generics business buyout
  5. Bayer, Loxo link in $1.55bn cancer drugs deal with $400M upfront
  6. Poxel has signed a deal with Sumitomo Dainippon Pharma to jointly develop its Type 2 Diabetes product Imeglimin
  7. Takeda taps Portal Instruments in needle-free drug delivery deal worth up to $100M
  8. Sanofi in $675 million deal with Principia to expand multiple sclerosis franchise
  9. Acerus Pharma enters hypogonadism drug licensing deal with Aspen for Brazil
  10. Grupo Biotoscana inks $30 million acquisition of Argentinian specialty pharmaceutical DOSA
  11. Zymeworks pens $50M upfront, $1B-plus biobucks Janssen bispecific pact
  12. Neurimmune collaborates with Ono Pharma for a novel therapeutic target for neurodegenerative diseases.

For more such news and updates, please join our Group "Global Life Science Business Partnering" on LinkedIn.

Updates at Aagami:

  • Aagami completes a business trip along with a UK Client with several fruitful term sheet level meetings with Top Indian companies  
  • Aagami team along with another client also successfully completed CEO level roadshow for strategic partnership in non-clinical/preclinical drug development strategies
  • Aagami registers for Biotech Showcase 2018